This being said, it would be great to see full data, hopefully including changes in body composition and physical fitness - if not here, then perhaps in some later trials Looking forward to full data presentation and also to further trials looking into possible cardioprotective and nephroprotective effects and influence on other complications of obesity #cagrisema #tirzepatide #cagrilintide #semaglutide #obesity #weightloss #REDEFINE4 Martin Haluzks Post Novo Nordisk A/S: 23% - -- 4 , REDEFINE 4 was an 84-week trial investigating CagriSema (a fixed dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg) compared to tirzepatide 15 mg, both administered once-weekly and subcutaneously
Results Patients typically see improvements in the targeted areas within a few weeks, with optimal results often visible after a series of treatments, depending on the individual and the area being treated
Given spironolactone has endocrine effects, it is plausible that it could increase the risk of hormonally dependent cancers, such as breast, ovarian, or endometrial cancers
ARP Rheumatol
How Does the Transsulfuration Pathway Support Liver Detoxification